ABOUT
Insight - Innovation - Access - Engagement - Partnering
The global partnering and investment summit for global leaders and innovators in CNS neurosciences and psychiatric drug discovery, development, platforms and technologies.
Convened by-invitation, Bio-Neuroscience is a high level, boutique gathering of key thought leaders, innovators and decision-makers from all key stakeholder groups crucial to the discovery, development and market launch of novel therapeutics and breakthrough platforms and technologies.
High level access, serious, sustained engagement, discussion and networking with key stakeholders. Sharing models, lessons learned, solutions, ways forward and best practices. A truly curated and unique summit to facilitate business and accelerate innovation.
ADVISORY BOARD
We are honored by the support of our advisory board.
Meet them in person at the summit.
 Stacie WeningerExecutive Director, F-Prime Biomedical Research Initiative |  David ReynoldsVenture Partner - SV Health Investors, CEO - LoQus23 Therapeutics |  Sourav KoleManaging Director - Dolby Family Ventures |  Joachim ScholppGlobal Head Translational Medicine CNS & Emerging Areas - Boehringer Ingelheim |
|---|---|---|---|
 Rita Balice-GordonChief Executive Officer - Muna Therapeutics |  Juan Carlos LopezManaging Director, Research Grants - RTW Charitable Foundation |  Mark TreherneChairperson, Monument Therapeutics |  Pieter van BokhovenChief Scientific Officer - Amsterdam Neuroscience IAO - VUMC |
 Andrea Soto Padilla, M.D. PhDBusiness Development - Amsterdam UMC |  Pawel ŚwiebodaCEO - EBRAINS & Director Generał - Human Brain Projec |  Christian J. SuojanenFounder & CEO - Broadreach Global, Member of the Board - European Brain Foundation |
WHO'S COMING?
Two days of sustained, interactive discussion, networking and partnering with:
Industry Leaders
Senior industry leaders from pharma, large biotech and healthcare companies. Heads of therapeutic area, R&D, clinical development, biological sciences, M&A, scouting, business development & licensing.
Key Opinion Leaders
Key Opinion Leaders from all stakeholder groups crucial to the successful development, approval and market launch of novel CNS neuroscience and psychiatric therapeutics, platforms and technologies.
Founders & CEOs
From startup and growth companies at the cutting edge of the future of CNS neuroscience and psychiatric drug discovery, development, advanced therapies, platforms and technologies.
Government & NGOs
Public agencies, funding bodies, foundations, societies, associations, patient organizations & NGOs in CNS neurosciences and psychiatry.
Investors
In CNS neuroscience and psychiatric drug development, platforms and technologies.
VC and corporate venture, private equity, family offices, angels & HNW.
Leading Advisors
A selected group of leading specialized advisors and consultants with deep subject matter expertise relevant to participants.
CO-ORGANIZED BY
HOST PARTNER
ORGANIZING PARTNER
GET IN TOUCH
Reach us here if you like to
-
Nominate a speaker
-
Apply to present your company or technology
-
Enquire about sponsorship & exhibition opportunities
Be the first to know
Subscribe and be among the first to receive all Broadreach Global updates, announcements and invitations.
Please make sure to double check your email address.
A Broadreach Global Initiative
Contact us at:
Follow us
